InsiderClue
Stocks · Health care · In Vitro & In Vivo Diagnostic Substances

MYRIAD GENETICS INC

MYGN Clue Score48
United States Fiscal year ends December CIK 0000899923
$4.31 +2.62% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $4.31 −86.20% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Revenue728.7Operating income44.0Net income17.4EPS, diluted0.25Fiscal year 2018Revenue743.7 +2.1%Operating income121.9Net income133.3 +666.1%EPS, diluted1.85 +640.0%Fiscal year 2019Revenue851.1 +14.4%Operating income7.6Net income4.6 −96.5%EPS, diluted0.06 −96.8%Fiscal year 2020Revenue638.6 −25.0%Operating income−231.7Net income−199.5 −4,437.0%EPS, diluted−2.69 −4,583.3%Fiscal year 2020Revenue557.1 −12.8%Operating income−289.7Net income−223.6EPS, diluted−2.99Fiscal year 2021Revenue690.6 +24.0%Operating income−190.5Net income−27.2EPS, diluted−0.35Fiscal year 2022Revenue678.4 −1.8%Operating income−140.6Net income−112.0EPS, diluted−1.39Fiscal year 2023Revenue753.2 +11.0%Operating income−257.4Net income−263.3EPS, diluted−3.18Fiscal year 2024Revenue837.6 +11.2%Operating income−123.5Net income−127.3EPS, diluted−1.41Fiscal year 2025Revenue824.5 −1.6%Operating income−387.2Net income−365.9EPS, diluted−3.95
FY2017FY2018FY2019FY2020FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 728.7 743.7 851.1 638.6 557.1 690.6 678.4 753.2 837.6 824.5
Growth +2.1% +14.4% −25.0% −12.8% +24.0% −1.8% +11.0% +11.2% −1.6%
Operating income 44.0 121.9 7.6 −231.7 −289.7 −190.5 −140.6 −257.4 −123.5 −387.2
Net income 17.4 133.3 4.6 −199.5 −223.6 −27.2 −112.0 −263.3 −127.3 −365.9
Growth +666.1% −96.5% −4,437.0%
EPS, diluted 0.25 1.85 0.06 −2.69 −2.99 −0.35 −1.39 −3.18 −1.41 −3.95
Growth +640.0% −96.8% −4,583.3%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2017Operating margin6.0%Net margin2.4%Free cash flow margin13.7%Fiscal year 2018Operating margin16.4%Net margin17.9%Free cash flow margin14.5%Fiscal year 2019Operating margin0.9%Net margin0.5%Free cash flow margin8.8%Fiscal year 2020Operating margin−36.3%Net margin−31.2%Free cash flow margin7.9%Fiscal year 2020Operating margin−52.0%Net margin−40.1%Fiscal year 2021Operating margin−27.6%Net margin−3.9%Free cash flow margin0.1%Fiscal year 2022Gross margin70.2%Operating margin−20.7%Net margin−16.5%Free cash flow margin−22.3%Fiscal year 2023Gross margin68.6%Operating margin−34.2%Net margin−35.0%Fiscal year 2024Gross margin69.9%Operating margin−14.7%Net margin−15.2%Fiscal year 2025Gross margin69.9%Operating margin−47.0%Net margin−44.4%
FY2017FY2018FY2019FY2020FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin n/a n/a n/a n/a n/a n/a 70.2% 68.6% 69.9% 69.9%
Operating margin 6.0% 16.4% 0.9% −36.3% −52.0% −27.6% −20.7% −34.2% −14.7% −47.0%
Net margin 2.4% 17.9% 0.5% −31.2% −40.1% −3.9% −16.5% −35.0% −15.2% −44.4%
Free cash flow margin 13.7% 14.5% 8.8% 7.9% n/a 0.1% −22.3% n/a n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow106.2Capital expenditure−6.1Free cash flow100.1Buybacks−31.6Fiscal year 2018Operating cash flow115.9Capital expenditure−8.4Free cash flow107.5 +7.4%Buybacks0.0Fiscal year 2019Operating cash flow83.7Capital expenditure−8.6Free cash flow75.1 −30.1%Buybacks−50.0Fiscal year 2020Operating cash flow60.7Capital expenditure−10.2Free cash flow50.5 −32.8%Buybacks0.0Fiscal year 2020Fiscal year 2021Operating cash flow18.6Capital expenditure−18.0Free cash flow0.6Buybacks0.0Fiscal year 2022Operating cash flow−106.3Capital expenditure−45.3Free cash flow−151.6 −25,366.7%Fiscal year 2023Operating cash flow−110.9Fiscal year 2024Operating cash flow−8.7Fiscal year 2025Operating cash flow1.8
FY2017FY2018FY2019FY2020FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 106.2 115.9 83.7 60.7 n/a 18.6 −106.3 −110.9 −8.7 1.8
Capital expenditure −6.1 −8.4 −8.6 −10.2 n/a −18.0 −45.3 n/a n/a n/a
Free cash flow 100.1 107.5 75.1 50.5 n/a 0.6 −151.6 n/a n/a n/a
Growth +7.4% −30.1% −32.8% −25,366.7%
Buybacks −31.6 0.0 −50.0 0.0 n/a 0.0 n/a n/a n/a n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2017Cash102.4Total debt99.1Net cash (debt)3.3Shareholders’ equity768.4Debt to equity0.13Fiscal year 2018Cash110.9Total debt9.3Net cash (debt)101.6Shareholders’ equity966.1Debt to equity0.01Fiscal year 2019Cash93.2Total debt233.5Net cash (debt)−140.3Shareholders’ equity1,088.9Debt to equity0.21Fiscal year 2020Cash163.7Total debt224.4Net cash (debt)−60.7Shareholders’ equity918.2Debt to equity0.24Fiscal year 2020Cash117.0Total debt224.8Net cash (debt)−107.8Shareholders’ equity881.0Debt to equity0.26Fiscal year 2021Cash257.4Total debt0.0Net cash (debt)257.4Shareholders’ equity967.8Debt to equity0.00Fiscal year 2022Cash56.9Total debt0.0Net cash (debt)56.9Shareholders’ equity885.8Debt to equity0.00Fiscal year 2023Cash132.1Total debt38.5Net cash (debt)93.6Shareholders’ equity783.2Debt to equity0.05Fiscal year 2024Cash102.4Total debt39.6Net cash (debt)62.8Shareholders’ equity701.1Debt to equity0.06Fiscal year 2025Cash149.6Total debt119.9Net cash (debt)29.7Shareholders’ equity368.0Debt to equity0.33
FY2017FY2018FY2019FY2020FY2020FY2021FY2022FY2023FY2024FY2025
Cash 102.4 110.9 93.2 163.7 117.0 257.4 56.9 132.1 102.4 149.6
Total debt 99.1 9.3 233.5 224.4 224.8 0.0 0.0 38.5 39.6 119.9
Net cash (debt) 3.3 101.6 −140.3 −60.7 −107.8 257.4 56.9 93.6 62.8 29.7
Shareholders’ equity 768.4 966.1 1,088.9 918.2 881.0 967.8 885.8 783.2 701.1 368.0
Debt to equity 0.13 0.01 0.21 0.24 0.26 0.00 0.00 0.05 0.06 0.33

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 30 Jun 2017 FY2018 30 Jun 2018 FY2019 30 Jun 2019 FY2020 30 Jun 2020 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
728.7 743.7 851.1 638.6 557.1 690.6 678.4 753.2 837.6 824.5
Growth +2.1% +14.4% −25.0% −12.8% +24.0% −1.8% +11.0% +11.2% −1.6%
145.2 n/a n/a n/a n/a n/a 202.0 236.2 252.2 247.9
n/a n/a n/a n/a n/a n/a 476.4 517.0 585.4 576.6
Growth +8.5% +13.2% −1.5%
74.4 70.8 85.9 77.2 73.3 81.9 85.4 88.7 113.4 106.8
439.9 435.0 556.6 507.3 496.9 537.8 514.7 572.9 275.9 256.8
44.0 121.9 7.6 −231.7 −289.7 −190.5 −140.6 −257.4 −123.5 −387.2
Growth +177.0% −93.8% −3,148.7%
36.2 120.1 0.0 −223.3 −283.6 −57.1 −140.6 −262.2 −123.5 −395.1
19.0 −13.0 −4.4 −23.7 −59.9 −29.9 −28.6 1.1 3.8 −29.2
17.4 133.3 4.6 −199.5 −223.6 −27.2 −112.0 −263.3 −127.3 −365.9
Growth +666.1% −96.5% −4,437.0%
Per share
0.25 1.92 0.06 −2.69 −2.99 −0.35 −1.39 −3.18 −1.41 −3.95
0.25 1.85 0.06 −2.69 −2.99 −0.35 −1.39 −3.18 −1.41 −3.95
Growth +640.0% −96.8% −4,583.3%
68.3 69.4 73.5 74.3 74.8 78.0 80.6 82.8 90.6 92.6
68.8 72.0 76.0 74.3 74.8 78.0 80.6 82.8 90.6 92.6
Growth +4.7% +5.6% −2.2% +0.7% +4.3% +3.3% +2.7% +9.4% +2.2%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 8.2% a year over five years.
  • The diluted share count rose 23.8% in five years, which is dilution.
  • Operating margin is up 5.0 points on five years ago, at -47.0%.
  • A net loss in 7 of 10 years on file.